Brian H. Kushner, MD
Pediatric Hematologist-Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Attending Physician
I am a pediatric oncologist at MSK Kids whose specialty is neuroblastoma, which can occur in babies, children, teenagers, and young adults. We have made great progress toward our goal of a cure with as few side effects as possible. For those whose neuroblastoma relapses, we have shown that a cure is still possible. Many patients come to us after they received treatment elsewhere, often because of problems such as relapse, poor response to therapy, or major side effects. Our team carefully discusses each patient’s unique situation and tailors an individualized plan of care to achieve the greatest chance of success.
Read more
I feel privileged to work as part of a team that focuses only on neuroblastoma. We see more patients with neuroblastoma than any other institution. Each patient is extremely important to us — we draw inspiration from every one of them and their families. Our exposure to patients from across the United States and from other countries affords us an extraordinary amount of experience and knowledge that we draw on each time we meet a new patient. In addition, because we treat so many patients, we are able to study the results of our treatments constantly, with a view toward identifying changes we can make right away to further improve cure rates and avoid side effects.
Our neuroblastoma team is dedicated to finding better treatments for this disease. One major effort is finding better ways to direct a patient’s own immune system to attack neuroblastoma. I am leading clinical trials assessing these new immunotherapies in patients with high-risk forms of this cancer.
We have also learned from the large number of patients we have cared for that in some cases, neuroblastoma disappears on its own. We are identifying factors that may predict which patients will experience such “spontaneous regression” and will be cured with little or no treatment.
I have covered the 26.2 miles of the New York City Marathon 15 times. I was on Fred’s Team, an organization of runners who raise funds to support cancer research at Memorial Sloan Kettering. During the most challenging parts of the marathon, I would picture in my mind the children and young adults we treat and how hard they fight for their lives, and I realized that what I was going through at those points in the race was nothing compared to what they endure. As we came to mile 17, on First Avenue in front of MSK, it was so exciting to high-five the patients and families who came out to watch us and to stop for a hug.
A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
My Specialties
- Pediatric Oncology
- Neuroblastoma
- Immunotherapy
Education
- MD, Johns Hopkins University
Residencies
- Pediatrics - Columbia-Presbyterian Medical Center
- Pediatrics - New York Hospital
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2002-2012, 2018, 2020)
Fellowships
- Pediatric Hematology/Oncology - Children's Hospital Boston and Memorial Sloan Kettering Cancer Center
Board Certifications
- Pediatrics
- Pediatric Hematology-Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Kushner sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Kushner
- A Phase 2 Study of a Vaccine in Combination With Beta-glucan for People With Neuroblastoma With a High Chance of Coming Back
- A Phase 2 Study of Reduced Chemotherapy and Antibody-Based Therapy in Children With Neuroblastoma
- A Phase II Study Assessing a Vaccine in Combination with Beta-glucan and GM-CSF in People with Neuroblastoma
- A Pilot Study of Shortened Induction Chemotherapy for Children with High-Risk Neuroblastoma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Kushner’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Brian H. Kushner discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].